Megan A. Foley

Indole Cytosolic Phospholipase A₂α Inhibitors: Discovery and in Vitro and in Vivo Characterization of 4-{3-[5-Chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1<i>H</i>-indol-3-yl]propyl}benzoic Acid, Efipladib

John C. McKew, Katherine L. Lee, Marina W. H. Shen et al. · Journal of Medicinal Chemistry · 2008 · 88 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Inhibition of Cytosolic Phospholipase A₂α: Hit to Lead Optimization

John C. McKew, Megan A. Foley, Paresh Thakker et al. · Journal of Medicinal Chemistry · 2005 · 77 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies

John W. Lampe, Joshua S. Alford, P. Ann Boriak-Sjodin et al. · ACS Medicinal Chemistry Letters · 2021 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Benzenesulfonamide indole inhibitors of cytosolic phospholipase A2α: Optimization of in vitro potency and rat pharmacokinetics for oral efficacy

Katherine L. Lee, Mark L. Behnke, Megan A. Foley et al. · Bioorganic & Medicinal Chemistry · 2007 · 28 citations

Medicine, Pharmacokinetics, Pharmacology +9

(+)-Rimocidin Synthetic Studies: Construction of the C(1−27) Aglycone Skeleton

Amos B. Smith, Megan A. Foley, Shuzhi Dong et al. · The Journal of Organic Chemistry · 2009 · 28 citations · Full text

Natural Sciences, Chemistry, Medicinal Chemistry +16